Rolando Cimaz Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

11/2022	Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort.
1/2022	Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation.
1/2022	Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study.
12/2021	A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis.
9/2021	Serum calprotectin (S100A8/9), clinical and ultrasound assessment in patients with juvenile idiopathic arthritis.
1/2021	Early Joint Replacement in Juvenile Idiopathic Arthritis: Trend Over Time and Factors Influencing Implant Survival.
1/2021	Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ.
1/2021	Th17 lymphocyte-dependent degradation of joint cartilage by synovial fibroblasts in a humanized mouse model of arthritis and reversal by secukinumab.
1/2021	Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
12/2020	Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rolando Cimaz Research Topics

Disease

53	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2022 - 10/2002
27	Uveitis 12/2021 - 07/2007
15	Inflammation (Inflammations) 01/2021 - 06/2005
14	Arthritis (Polyarthritis) 01/2022 - 03/2003
12	Rheumatic Diseases (Rheumatism) 01/2021 - 07/2002
11	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021 - 11/2005
10	Autoimmune Diseases (Autoimmune Disease) 05/2020 - 06/2003
10	Congenital heart block 01/2019 - 01/2002
8	Infections 01/2021 - 09/2003
7	Vasculitis (Vasculitides) 01/2022 - 04/2010
7	Fever (Fevers) 08/2018 - 07/2012
6	Rheumatoid Arthritis 01/2022 - 07/2007
5	Dermatomyositis (Dermatopolymyositis) 01/2020 - 01/2011
5	Neonatal Systemic lupus erythematosus 01/2019 - 01/2002
5	Blau syndrome 07/2018 - 04/2011
5	Osteoporosis 09/2017 - 07/2002
5	Myositis (Idiopathic Inflammatory Myopathies) 05/2017 - 03/2012
4	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2022 - 11/2008
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 09/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 10/2011
4	COVID-19 01/2021 - 04/2020
4	Macrophage Activation Syndrome 06/2020 - 12/2012
4	Pericarditis 09/2016 - 07/2012
3	Systemic Vasculitis 01/2022 - 10/2013
3	Pain (Aches) 01/2022 - 01/2016
3	Proteinuria 01/2020 - 01/2017
3	Panuveitis 01/2018 - 02/2013
3	Necrosis 05/2013 - 07/2007
3	Exanthema (Rash) 11/2012 - 06/2003
2	Hemorrhage 01/2022 - 08/2018
2	Osteoarthritis 01/2022 - 01/2020
2	Disease Progression 12/2021 - 12/2020
2	Adult-Onset Still's Disease 11/2020 - 01/2019
2	Chorea (Rheumatic Chorea) 06/2020 - 03/2010
2	Sarcoidosis (Schaumann Disease) 03/2020 - 01/2016
2	Amyloidosis 01/2020 - 02/2012
2	Abdominal Pain (Pain, Abdominal) 01/2020 - 11/2012
2	Rheumatic Fever (Acute Articular Rheumatism) 06/2019 - 10/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 04/2019 - 01/2015
2	Myocarditis (Carditis) 08/2018 - 12/2002
2	Multifocal Choroiditis 01/2018 - 01/2016
2	Serositis 01/2017 - 11/2012
2	Hypoalbuminemia 01/2017 - 11/2016
2	Hyponatremia 01/2017 - 11/2016

Drug/Important Bio-Agent (IBA)

18	Biological ProductsIBA 01/2021 - 02/2011
13	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2020 - 02/2011
12	Pharmaceutical PreparationsIBA 12/2021 - 01/2006
11	Methotrexate (Mexate)FDA LinkGeneric 06/2021 - 01/2013
10	AntibodiesIBA 03/2022 - 12/2002
10	AutoantibodiesIBA 01/2021 - 01/2002
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 07/2007
9	Adalimumab (Humira)FDA Link 12/2021 - 04/2011
9	CytokinesIBA 01/2021 - 07/2007
8	Immunosuppressive Agents (Immunosuppressants)IBA 11/2020 - 06/2005
7	Prednisone (Sone)FDA LinkGeneric 06/2020 - 01/2014
7	Antirheumatic Agents (DMARD)IBA 05/2020 - 01/2013
7	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 11/2005
6	canakinumab FDA Link 11/2022 - 06/2012
6	Etanercept (Enbrel)FDA Link 06/2021 - 01/2013
6	Abatacept (Orencia)FDA Link 01/2021 - 06/2010
6	Interleukin-1 (Interleukin 1)IBA 12/2020 - 07/2007
6	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2020 - 05/2011
6	Tumor Necrosis Factor InhibitorsIBA 12/2020 - 07/2007
6	SteroidsIBA 06/2020 - 04/2011
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2017 - 06/2005
6	EnzymesIBA 01/2016 - 06/2005
5	C-Reactive ProteinIBA 10/2021 - 12/2012
5	GlucocorticoidsIBA 01/2021 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 07/2018 - 12/2002
5	Diphosphonates (Bisphosphonates)IBA 09/2017 - 09/2010
4	Biomarkers (Surrogate Marker)IBA 03/2022 - 03/2013
4	AntigensIBA 01/2022 - 12/2013
4	Antiphospholipid AntibodiesIBA 01/2021 - 09/2005
4	Colchicine FDA LinkGeneric 01/2020 - 08/2010
4	InterleukinsIBA 01/2019 - 05/2013
4	SS-A antibodiesIBA 11/2017 - 01/2002
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2017 - 03/2012
4	Infliximab (Remicade)FDA Link 01/2013 - 03/2011
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 08/2017
3	Rituximab (Mabthera)FDA Link 01/2022 - 01/2017
3	Peptides (Polypeptides)IBA 12/2021 - 06/2005
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2019 - 05/2011
3	InflammasomesIBA 04/2019 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 04/2017 - 09/2009
3	AdipokinesIBA 03/2013 - 11/2011
3	Interleukin-17 (Interleukin 17)IBA 04/2012 - 09/2009
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 01/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 09/2016
2	InterferonsIBA 01/2022 - 08/2012
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2020
2	Ferritins (Ferritin)IBA 03/2021 - 10/2014
2	MicroRNAs (MicroRNA)IBA 06/2019 - 01/2013
2	LigandsIBA 11/2017 - 05/2004
2	Immunoglobulins (Immunoglobulin)IBA 08/2017 - 11/2005

Therapy/Procedure

38	Therapeutics 01/2022 - 07/2002
3	Biological Therapy 06/2020 - 12/2016
2	Viscosupplementation 01/2022 - 01/2020
2	Injections 06/2021 - 01/2020
2	Time-to-Treatment 01/2020 - 02/2016
2	Aftercare (After-Treatment) 01/2017 - 06/2010